Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Business Briefs

This article was originally published in The Gray Sheet

Executive Summary

Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.

You may also be interested in...

Medtronic Vet Christopher Barry Takes Helm At Nuvasive

About three years after becoming CEO of NuVasive, Gregory Lucier is ceding the role to Barry, who has led Medtronic's Surgical Innovations business, effective Nov. 5. Lucier will continue to serve as chairman of the board for the San Diego-based minimally-invasive spine surgery technology company.

NuVasive Names New President, Taps Former Prez As Vice Chair

NuVasive promoted Jason M. Hannon to be president and COO. The company’s former president, Patrick S. Miles, has been tapped to serve as vice chairman.

People Briefs

NuVasive appoints executive VP, general counsel; Danaher names senior VP and general counsel; and genomic informatics company Human Longevity acquires Cypher Genomics, and in the process names Cypher CEO Ashley Van Zeeland as head of the firm's pediatric business.

Related Content

Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts